» Articles » PMID: 36768336

Altered Fatty Acid Oxidation in Lymphocyte Populations of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2023 Feb 11
PMID 36768336
Authors
Affiliations
Soon will be listed here.
Abstract

Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) is a disabling multisystem illness in which individuals are plagued with fatigue, inflammatory symptoms, cognitive dysfunction, and the hallmark symptom, post-exertional malaise. While the cause of this disease remains unknown, there is evidence of a potential infectious component that, along with patient symptoms and common onsets of the disease, implicates immune system dysfunction. To further our understanding of the state of ME/CFS lymphocytes, we characterized the role of fatty acids in isolated Natural Killer cells, CD4+ T cells, and CD8+ T cells in circulation and after overnight stimulation, through implicit perturbations to fatty acid oxidation. We examined samples obtained from at least 8 and as many as 20 subjects for immune cell fatty acid characterization in a variety of experiments and found that all three isolated cell types increased their utilization of lipids and levels of pertinent proteins involved in this metabolic pathway in ME/CFS samples, particularly during higher energy demands and activation. In T cells, we characterized the cell populations contributing to these metabolic shifts, which included CD4+ memory cells, CD4+ effector cells, CD8+ naïve cells, and CD8+ memory cells. We also discovered that patients with ME/CFS and healthy control samples had significant correlations between measurements of CD4+ T cell fatty acid metabolism and demographic data. These findings provide support for metabolic dysfunction in ME/CFS immune cells. We further hypothesize about the consequences that these altered fuel dependencies may have on T and NK cell effector function, which may shed light on the illness's mechanism of action.

Citing Articles

The search for a blood-based biomarker for Myalgic Encephalomyelitis/ Chronic Fatigue Syndrome (ME/CFS): from biochemistry to electrophysiology.

Clarke K, Kingdon C, Hughes M, Lacerda E, Lewis R, Kruchek E J Transl Med. 2025; 23(1):149.

PMID: 39905423 PMC: 11792299. DOI: 10.1186/s12967-025-06146-6.


Two Different Hemodynamic Responses in ME/CFS Patients with Postural Orthostatic Tachycardia Syndrome During Head-Up Tilt Testing.

van Campen C, Rowe P, Visser F J Clin Med. 2025; 13(24.

PMID: 39768649 PMC: 11677391. DOI: 10.3390/jcm13247726.


Transcriptional reprogramming primes CD8+ T cells toward exhaustion in Myalgic encephalomyelitis/chronic fatigue syndrome.

Iu D, Maya J, Vu L, Fogarty E, McNairn A, Ahmed F Proc Natl Acad Sci U S A. 2024; 121(50):e2415119121.

PMID: 39621903 PMC: 11648872. DOI: 10.1073/pnas.2415119121.


Towards an understanding of physical activity-induced post-exertional malaise: Insights into microvascular alterations and immunometabolic interactions in post-COVID condition and myalgic encephalomyelitis/chronic fatigue syndrome.

Haunhorst S, Dudziak D, Scheibenbogen C, Seifert M, Sotzny F, Finke C Infection. 2024; 53(1):1-13.

PMID: 39240417 PMC: 11825644. DOI: 10.1007/s15010-024-02386-8.


Dysregulation of tetrahydrobiopterin metabolism in myalgic encephalomyelitis/chronic fatigue syndrome by pentose phosphate pathway.

Bulbule S, Gottschalk C, Drosen M, Peterson D, Arnold L, Roy A J Cent Nerv Syst Dis. 2024; 16:11795735241271675.

PMID: 39161795 PMC: 11331476. DOI: 10.1177/11795735241271675.


References
1.
Keating S, Zaiatz-Bittencourt V, Loftus R, Keane C, Brennan K, Finlay D . Metabolic Reprogramming Supports IFN-γ Production by CD56bright NK Cells. J Immunol. 2016; 196(6):2552-60. DOI: 10.4049/jimmunol.1501783. View

2.
Zalocusky K, Kan M, Hu Z, Dunn P, Thomson E, Wiser J . The 10,000 Immunomes Project: Building a Resource for Human Immunology. Cell Rep. 2018; 25(2):513-522.e3. PMC: 6263160. DOI: 10.1016/j.celrep.2018.09.021. View

3.
Cliff J, King E, Lee J, Sepulveda N, Wolf A, Kingdon C . Cellular Immune Function in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS). Front Immunol. 2019; 10:796. PMC: 6477089. DOI: 10.3389/fimmu.2019.00796. View

4.
Nicholas D, Proctor E, Agrawal M, Belkina A, Van Nostrand S, Panneerseelan-Bharath L . Fatty Acid Metabolites Combine with Reduced β Oxidation to Activate Th17 Inflammation in Human Type 2 Diabetes. Cell Metab. 2019; 30(3):447-461.e5. PMC: 8506657. DOI: 10.1016/j.cmet.2019.07.004. View

5.
Poznanski S, Ashkar A . What Defines NK Cell Functional Fate: Phenotype or Metabolism?. Front Immunol. 2019; 10:1414. PMC: 6593107. DOI: 10.3389/fimmu.2019.01414. View